Skip to main content
AmigoFish

STIFEL 2026: REGENXBIO will have its pivotal studies for wet AMD read out before the end of the year - combined, they are the largest study of a gene therapy ever

From BiotechTV - News · · 8 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

CEO Curran Simpson sets the table for the readouts and describes what he believes they need to show in order to succeed. Plus, updates on the DMD program and RGX-121.

Back to BiotechTV - News · Report a problem